<?xml version='1.0' encoding='iso-8859-1'?>
<newsitem date="1997-05-01" id="root" itemid="554068" xml:lang="en">
<title>USA: AutoImmune says will cut staff.</title>
<headline>AutoImmune says will cut staff.</headline>
<dateline>LEXINGTON, Mass. 1997-05-01</dateline>
<text>
<p>AutoImmune Inc (Nasdaq: AIMM) said Thursday it is cutting its staff from 74 to 51 full-time employees.</p>
<p>The company said this move reflects the previously announced disappointing preliminary results of the myloral phase III trial. All the jobs the company is cutting relate to the myloral program.</p>
<p>The company said it will redirect its resources toward the clinical development of colloral, its product for rheumatoid arthritis.</p>
<p>The company said it expects to report the collaral phase III data in May, and plans to begin the trial later this year.</p>
<p>The company reported a a net loss of $7.6 million, or $0.47 per share, for the quarter compared with a net loss of $4.1 million, or $0.25 per share, for the same quarter one year earlier.</p>
<p>The company said its increase it research and development expenses to $7.5 million from $4.3 million reflect the its spending for two products in late stage trials.</p>
<p>AutoImmune Inc is a biopharmaceutical company developing drug therapies for the treatment of autoimmune diseases.</p>
</text>
<copyright>(c) Reuters Limited 1997</copyright>
<metadata>
<dc element="dc.date.created" value="1997-05-01" />
<dc element="dc.publisher" value="Reuters Holdings Plc" />
<dc element="dc.date.published" value="1997-05-01" />
<dc element="dc.source" value="Reuters" />
<dc element="dc.creator.location" value="LEXINGTON, Mass." />
<dc element="dc.creator.location.country.name" value="USA" />
<dc element="dc.source" value="Reuters" />
</metadata>
</newsitem>